Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity
Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity
复制标题
急性精神分裂症伴有T细胞减少和B细胞免疫力增加
DOI:
10.1007/s00406-010-0098-x
复制
发表时间:
2010
影响因子:
4.7
通讯作者:
Bogerts B.
中科院分区:
文献类型:
--
作者:
Steiner J;Jacobs R;Panteli B;Brauner M;Schiltz K;Bahn S;Herberth M;Westphal S;Walter M;Bernstein H;Myint AM;Bogerts B.
Previous studies of lymphocyte distribution in schizophrenia have yielded inconsistent results, as summarized in the present study. Based on our own original data, potential confounds that might explain these variations are analyzed and discussed. Blood samples from 26 patients with acute paranoid schizophrenia were investigated in comparison with 32 matched healthy controls by flow cytometry (CD3, CD4, CD8, CD19, and CD56 phenotyping). A subgroup of drug-free patients was followed up after 6 weeks of treatment. Cotinine levels and the free cortisol index (FCI) were provided in order to control for medication, smoking, and stress. Cotinine levels correlated with natural killer (NK) cell counts (CD3−/CD56+:r= −0.383,P= 0.003) while the FCI was related to B cell numbers (CD19+:r= 0.390,P= 0.003). Considering these covariates, a lower level of T helper cells (P= 0.010), a reduced CD4/CD8 ratio (P= 0.029), and elevated B cells (P= 0.008) were found during acute psychosis. After 6 weeks of medication, an inverse pattern was observed in initially drug-free patients: total T cell (P= 0.005), T helper (P= 0.003), and T suppressor/cytotoxic cells (P= 0.005) increased, while B cell counts declined (P= 0.049). In conclusion, acute paranoid schizophrenia may be accompanied by a reduced T cell defense and a shift towards B cell immunity, which normalizes in response to treatment. In addition to disease stage or subtype and medication, cigarette smoking and stress are important co-factors.
登录
查看更多内容
影响因子:
4.4
作者:
Yuemei Geng;S. M. Savage;S. Razani;M. Sopori
通讯作者:
M. Sopori
影响因子:
10.5
作者:
S. Shrikhande;S. Hirsch;J. Coleman;M. Reveley;R. Dayton
通讯作者:
R. Dayton
影响因子:
3.7
作者:
S. Wüst;I. Federenko;E. Rossum;J. Koper;D. Hellhammer
通讯作者:
D. Hellhammer
影响因子:
4.5
作者:
B. Sperner-Unterweger;A. Whitworth;G. Kemmler;W. Hilbe;J. Thaler;G. Weiss;W. Fleischhacker
通讯作者:
B. Sperner-Unterweger;A. Whitworth;G. Kemmler;W. Hilbe;J. Thaler;G. Weiss;W. Fleischhacker
DOI:
10.1124/jpet.302.3.935
发表时间:
2002-09
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
Roma Kalra;S. Singh;D. Kracko;S. Matta;B. Sharp;M. Sopori
通讯作者:
Roma Kalra;S. Singh;D. Kracko;S. Matta;B. Sharp;M. Sopori